Product
Supplier
Encyclopedia
Inquiry
Home > Encyclopedia > Proglumide

Proglumide

pharmaceutical raw materials
Proglumide structure

Proglumide 

structure
  • CAS No:

    6620-60-6

  • Formula:

    C18H26N2O4

  • Chemical Name:

    Proglumide

  • Synonyms:

    Pentanoic acid,4-(benzoylamino)-5-(dipropylamino)-5-oxo-;Glutaramic acid,4-benzamido-N,N-dipropyl-,DL-;Pentanoic acid,4-(benzoylamino)-5-(dipropylamino)-5-oxo-,(±)-;4-(Benzoylamino)-5-(dipropylamino)-5-oxopentanoic acid;DL-4-Benzamido-N,N-dipropylglutaramic acid;Proglumide;CR 242;Xyde;Xylamide;Xylamide (gastroprotective agent);Milid;W 5219;Binoside;Gastrotopic;Midelid;Milide;Nulsa;Ulcutin;Promide (parasympatholytic);(±)-Proglumide;DL-Proglumide;Promid;24485-90-3;25727-74-6

  • Categories:

    Active Pharmaceutical Ingredients  >  Digestive System Drugs

Description

Proglumide is a known cholecystokinin (CCK) antagonist.


Proglumide is a racemate composed of equal amounts of (R)- and (S)-proglumide. A non-selective CCK antagonist that was used primarily for treatment of stomach ulcers, but has been replaced by newer drugs. It has a role as a drug metabolite, a xenobiotic metabolite, a cholinergic antagonist, an anti-ulcer drug, a cholecystokinin antagonist, a gastrointestinal drug, a delta-opioid receptor agonist and an opioid analgesic. It contains a (R)-proglumide and a (S)-proglumide.|A drug that exerts an inhibitory effect on gastric secretion and reduces gastrointestinal motility. It is used clinically in the drug therapy of gastrointestinal ulcers.

Proglumide Basic Attributes

334.41

334.41

229-567-4

757841

DTXSID7023516

A - Alimentary tract and metabolism

2924299090

Characteristics

86.7

2.53

1.1±0.1 g/cm3

143.5 °C

589.8±45.0 °C at 760 mmHg

310.5±28.7 °C

1.534

Refrigerator

Celiac-rat LD50: 1420 mg/kg; Oral-Mouse LD50: 8070 mg/kg

Flammable; burning produces toxic nitrogen oxide fumes

181.1 Ų [M+H]+ [CCS Type: TW, Method: calibrated with polyalanine and drug standards]

Safety Information

Ventilated, low temperature and dry

Toxicity

moderately toxic

Drug Information

Various agents with different action mechanisms used to treat or ameliorate PEPTIC ULCER or irritation of the gastrointestinal tract. This has included ANTIBIOTICS to treat HELICOBACTER INFECTIONS; HISTAMINE H2 ANTAGONISTS to reduce GASTRIC ACID secretion; and ANTACIDS for symptomatic relief. (See all compounds classified as Anti-Ulcer Agents.)

Milid

Proglumide Use and Manufacturing

Uses

Anticholinergic.

Pharmaceuticals

Computed Properties

Molecular Weight:334.4
XLogP3:2.4
Hydrogen Bond Donor Count:2
Hydrogen Bond Acceptor Count:4
Rotatable Bond Count:10
Exact Mass:334.18925731
Monoisotopic Mass:334.18925731
Topological Polar Surface Area:86.7
Heavy Atom Count:24
Complexity:413
Undefined Atom Stereocenter Count:1
Covalently-Bonded Unit Count:1
Compound Is Canonicalized:Yes

Material

Drug Function and Efficacy

This product is a gastrin receptor antagonist, which can significantly inhibit the secretion of gastric acid and pepsin caused by gastrin, but has no significant effect on the gastric acid secretion caused by histamine and vagus nerve stimulation. It can increase the content of hexosamine in the gastric mucosa, promote glycoprotein synthesis, and protect and promote the healing of the gastric mucosa. It has a choleretic effect, preventing stone formation and promoting bile duct health by stimulating bile acid-independent bile secretion, changing the stone-forming factors in bile, and antagonizing CCK.

This ingredient has been used in drugs with the following functions (note: it does not mean that the ingredient itself has the following health functions)

Related Drugs

Registered Holders

Recommended Suppliers of Proglumide

Scan the QR Code to Share

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.